Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers

Chulalongkorn University

Status: Completed

Conditions: Lipolysis

Treatments: Other: Placebo; Other: Resveratrol lipoic Acid

Study type: Interventional

Funder types: Other

Identifiers

NCT03062163

nanolab817

Details and patient eligibility

About

To evaluate the lipolysis effect of resveratrol and lipoic acid transdermal patch in overweight volunteers

Full description

66 participants with overweight received a resveratrol and lipoic acid transdermal patch treatment. The treatment areas have been treated including left and right arms. Subjects were evaluated using standardized measurements of body weight and circumference of arms at baseline and 2 weeks follow-up visits. Evaluation of physician were also measured.

Enrollment: 66 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy volunteers with BMI > 23

Exclusion criteria

• resveratrol or lipoic acid allergies

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

66 participants in 2 patient groups

Resveratrol lipoic Acid

Experimental group

Description:

lipoic and resveratrol was loaded on the patch

Treatment:

Other: Resveratrol lipoic Acid

Placebo

Experimental group

Description:

normal saline was loaded on transdermal patch

Treatment:

Other: Placebo